Clearside Biomedical, Inc., a biopharmaceutical company, develops and delivers treatment that restore and preserve vision for people with serious eye diseases. Its preclinical products include CLS-AX, an axitinib for suprachoroidal injection. It also develops XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of macular edema associated with uveitis, diabetic macular edema, and macular edema associated with retinal vein occlusion. The company was founded in 2011 and is headquartered in Alpharetta, Georgia.
http://www.priceseries.com/trade/CLSD-Clearside-Biomedical-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2021082020210903.html
Subscribe by Email
Follow Updates Articles from This Blog via Email
No Comments